From: The value of lung function assessment and Testin expression detection in clinicopathological features and prognosis of NSCLC patients
Variables
Overall survival
Hazard radio
95% CI
p
Age
1.067
1.043–1.092
<0.0001
Stage
1.584
1.075–2.334
0.02
Testin
0.123
0.076–0.198
Group of PRISm and COPD
1.299
1.048–1.610
0.017